Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02787551
What this trial is testing

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 514
Not applicableStudy completedNCT05875636
What this trial is testing

GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy

Who this might be right for
Gastric Content Aspiration
Medical University of South Carolina 260
Early research (Phase 1)Study completedNCT05882032
What this trial is testing

LY3502970 in Participants With Impaired and Normal Liver Function

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 29
Not applicableStudy completedNCT03993132
What this trial is testing

A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 26,774
Not applicableStudy completedNCT06355219
What this trial is testing

Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines

Who this might be right for
Type 2 Diabetes MellitusObesityMicrovascular Disease+6 more
Ali Aminian 3,932
Not applicableNot Yet RecruitingNCT07787936
What this trial is testing

GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

Who this might be right for
Heart Failure With Preserved Ejection FractionObesityDiastolic Heart Failure+2 more
Miedziowe Centrum Zdrowia SA 150
Not applicableLooking for participantsNCT07091500
What this trial is testing

Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity

Who this might be right for
ObesitySkeletal MuscleBrain Connectivity
Washington University School of Medicine 40
Not applicableActive Not RecruitingNCT06467604
What this trial is testing

CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users

Who this might be right for
Obesity
University of California, Davis 7
Not applicableLooking for participantsNCT07605572
What this trial is testing

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

Who this might be right for
Dry Eye Disease (DED)Diabete MellitusGLP-1+3 more
Attikon Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT07497399
What this trial is testing

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Johns Hopkins University 120
Large-scale testing (Phase 3)Study completedNCT00712673
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 680
Not applicableNot Yet RecruitingNCT07708610
What this trial is testing

Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes

Who this might be right for
PneumoniaType 2 Diabetes Mellitus (T2DM)
Chung Shan Medical University 71,775
Not applicableLooking for participantsNCT07728669
What this trial is testing

Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)Overweight+1 more
Kazakh Academy of Nutrition 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT07617155
What this trial is testing

GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis

Who this might be right for
Hypertriglyceridemia Induced Acute PancreatitisRecurrent Acute PancreatitisPancreatitis Relapsing+1 more
Peking Union Medical College Hospital 396
Large-scale testing (Phase 3)Not Yet RecruitingNCT06788626
What this trial is testing

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment

Who this might be right for
Acute Ischemic StrokeLarge Vessel OcclusionNeuroprotective Drugs+1 more
Wei Hu 390
Post-approval studies (Phase 4)Study completedNCT05218915
What this trial is testing

Basal Plus GLP1-ra on Glycemic Variability in CKD

Who this might be right for
Diabetes MellitusDiabetic Kidney Disease
Elaine Chow 95
Very early researchLooking for participantsNCT07627191
What this trial is testing

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

Who this might be right for
Pancreatic CancerColorectal CancerHepatocellular Carcinoma
University of Arizona 30
Post-approval studies (Phase 4)Study completedNCT07732218
What this trial is testing

Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial

Who this might be right for
Type 2 Diabetes
Rehman Medical Institute - RMI 95
Large-scale testing (Phase 3)Study completedNCT07820111
What this trial is testing

Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial

Who this might be right for
Obese DiabeticsObese Non Diabetic
Zagazig University 159
Post-approval studies (Phase 4)Looking for participantsNCT07558863
What this trial is testing

Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetes With Diabetic Autonomic Neuropathy (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University 60
Next Page